Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-09-12

Clinical Trial Update: An Efficacy/Safety Study of Perampanel for Reducing Essential Tremor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of perampanel for reducing essential tremor. The study is sponsored by the VA Greater Los Angeles Heal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perampanel (perampanel)

Snippet

Sponsor: VA Greater Los Angeles Healthcare System | Conditions: Essential Tremor | Phase 2 | Status: UNKNOWN